Valuation : Scinai Immunotherapeutics Ltd.

Market Cap 1.06M 912K 858K 784K 1.47M 100M 1.47M 10.14M 3.94M 51.36M 3.98M 3.89M 165M P/E 2024 *
-
P/E 2025 -0.2x
Enterprise Value 1.67M 1.43M 1.35M 1.23M 2.31M 157M 2.31M 15.94M 6.19M 80.72M 6.26M 6.12M 260M EV / Sales 2024
4,521,658x
EV / Sales 2025 2,346,086x
Free-Float
0.36%
Yield 2024 *
-
Yield 2025 -
1 day-4.62%
1 week-25.90%
Current month-25.60%
1 month-25.60%
3 months-54.89%
6 months-77.12%
Current year-73.88%
1 week 1.85
Extreme 1.85
2.7
1 month 1.85
Extreme 1.85
3.58
Current year 1.85
Extreme 1.85
11.2
1 year 1.85
Extreme 1.85
16.4
3 years 1.85
Extreme 1.85
137
5 years 1.85
Extreme 1.85
3,490
10 years 1.85
Extreme 1.85
61,999.9
Manager TitleAgeSince
Chief Executive Officer 51 02/03/2021
Director of Finance/CFO 55 01/01/2007
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Chairman 77 30/09/2019
Director/Board Member 64 24/03/2020
Director/Board Member 71 24/03/2020
Date Insider Type Main position Quantity % Market Cap. Importance
18/3/26 Other

Chief Financial Officer

35,848,348 1.0507%
18/3/26 Other

Director

57,400,000 1.6823%
18/3/26 Other

Director

60,400,000 1.7702%
Change 5-day change 1-year change 3-year change Capi.($)
-4.62%-25.90%-87.60%-98.58% 1.06M
-2.54%-2.84%-1.77%+14.72% 48.93B
-0.40%+1.03%+418.57%+523.39% 45.01B
-1.42%+2.30%+42.67%+21.22% 44.07B
-1.22%-2.31%+4.82%+74.90% 40.73B
+0.53%-1.36%+16.87%+47.12% 33.52B
-0.21%+9.14% - - 17.77B
-0.35%-1.56%+21.42%+123.04% 16.5B
-1.01%+0.50%+13.91%+31.45% 14.67B
-1.65%-1.03%+75.93%+41.22% 13.77B
Average -1.29%-2.11%+56.09%+86.50% 27.5B
Weighted average by Cap. -1.03%+0.11%+89.42%+127.93%

Financials

2024 2025
Net sales 0.66 0.57 0.53 0.49 0.91 62.13 0.91 6.3 2.44 31.87 2.47 2.42 102.69 1.31 1.13 1.06 0.97 1.81 123.78 1.82 12.54 4.87 63.51 4.92 4.82 204.59
Net income 4.8M 4.13M 3.88M 3.55M 6.64M 453M 6.65M 45.88M 17.8M 232M 18.01M 17.62M 748M -8.31M -7.15M -6.73M -6.14M -11.49M -784M -11.52M -79.47M -30.84M -402M -31.19M -30.51M -1.3B
Net Debt 122K 105K 98.77K 90.23K 169K 11.52M 169K 1.17M 453K 5.91M 458K 448K 19.04M 606K 521K 491K 448K 838K 57.22M 841K 5.8M 2.25M 29.36M 2.28M 2.23M 94.57M
Logo Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
Employees
45
Date Price Change Volume
04/09/26 USD 1.860 -4.62% 84,670
03/09/26 USD 1.950 -16.67% 191,665
02/09/26 USD 2.340 -4.88% 1,611,978
01/09/26 USD 2.460 -1.60% 56,454
31/08/26 USD 2.500 -0.40% 24,866

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SCNI Stock